Status:
RECRUITING
REGistry of Long-term AnTithrombotic TherApy-1
Lead Sponsor:
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions:
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes
Detailed Description
The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with chronic coronary syndromes
Eligibility Criteria
Inclusion
- coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging
Exclusion
- Subjects who are unwilling or unable to provide informed consent.
- Acute coronary syndrome within 12 months before inclusion
- Severe chronic heart failure (NYHA IV)
- Stroke within 6 months before inclusion
- Severe liver or muscle disease
- Severe kidney disease / renal failure with creatinine \> 3 mg/dl
- Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -
Key Trial Info
Start Date :
January 15 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04347200
Start Date
January 15 2015
End Date
January 31 2026
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Moscow, Russia, 121552